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Abstract
Objectives
The current study aims to identify markers that would reflect the number of Leydig cells pres-
ent in the testis, to help determine whether labour-intensive methods such as stereology are
necessary. We used our well-characterised Sertoli cell ablation model in which we have
empirically established the size of the Leydig cell population, to try to identify transcriptional
biomarkers indicative of population size.
Results
Following characterisation of the Leydig cell population after Sertoli cell ablation in neonatal
life or adulthood, we identified Hsd3b1 transcript levels as a potential indicator of Leydig cell
number with utility for informing decision-making on whether to engage in time-consuming
stereological cell counting analysis.
Introduction
Androgens are critical for male development, fertility and well-being [1–4]. The principal
source of androgens in the male are the testicular Leydig cells (LCs), which develop in two
sequential waves or populations. The first population to develop are the fetal Leydig cells
(FLCs), which appear soon after testis differentiation and act to ensure masculinisation of the
fetus. After birth, a second “adult” Leydig cell (ALC) population starts to develop in the mouse
at around 7–10 days [5–7]. These cells generate a pubertal surge of testosterone, which acts to
promote and maintain adult fertility and to drive male reproductive behaviour. Our group has
recently shown that the Sertoli cells (SCs), key regulators of testis differentiation and adult
spermatogenesis, also control both the differentiation and development of the ALC population
in neonatal life, and their survival in adulthood [8, 9]. Additionally, SC number was shown to
be a biomarker of ALC population size [10]. However, these studies relied on the application
of thorough biomolecular and stereological approaches to determine cell population sizes, the
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latter being somewhat time-consuming. Identification of a biomarker that is predictive of a
change in LC population size would speed preliminary analysis, and inform a decision on
whether more time-consuming stereological counting is likely to be informative.
To this end, we used our well-characterised SC ablation model in which we have empirically
established the size of the LC population to try to identify transcriptional biomarkers indica-
tive of population size. We know that, in this model, SC ablation in adulthood leads to loss of
75% of the LC population. However, the 25% of LCs that remain after SC ablation in the adult
are able to maintain basal testosterone levels in the mice although the pulsatile peak levels of
hormone are reduced [8], suggesting that the remaining LCs are showing increased levels of
activity. Therefore, this provides a unique opportunity to identify LC transcripts that accu-
rately reflect the size of the LC population, as opposed to those that change in response to a
functional compensation for a reduction in population size.
To address this, we first determined the characteristics of the LCs following SC ablation,
using histological and bio molecular approaches. We then utilised this model to identify gene
transcripts that can be utilised as indicators of a change in ALC number for use in future
studies.
Results discussion
Postnatal retention of fetal-like-LCs is independent of SCs
Having previously determined the gross impact of SC ablation on testis development and func-
tion at different endpoints [8, 10], we performed a further, more detailed analysis of the LCs.
In the adult testis, following ablation of SCs at postnatal day 2 (pnd2-neonatal), the overall
tubular architecture was disrupted, and only the tubuli recti and rete testis were maintained
due to the retention of SC-like cells in these structures. A large group of ALCs (characterised
by large round nucleus and abundant cytoplasm) [11] formed a cluster around the cells of the
tubuli recti, near the rete testis (Fig 1A and 1B blue arrows), coinciding with the retention of
LC progenitors in the vicinity of the rete testis, as previously described [8]. This observation
was confirmed by immunohistochemical staining, demonstrating that these cells expressed
CYP11A1 and CYP17A1, both specific markers of LCs in the testis (Fig 1C and 1D red
arrows). However, the staining also revealed the presence of another group of LCs further
away from the rete testis (Fig 1C and 1D blue arrows). This group of LCs, dispersed in small
clusters of 3 or 4 cells exhibited more punctate nuclei and reduced cytoplasmic volume (Fig 1E
black arrowhead), similar to the morphology and size of FLCs seen in control neonatal (pnd2)
mice (Fig 1F black arrowhead, compare to ALCs in Fig 1A). We suggest that these FLC-like
cells are retained, consistent with recent literature showing FLCs are retained through to adult-
hood [12–15] and further supports the hypothesis that FLCs are independent of the SCs [16].
The cells would however, require further characterisation.
LC-specific transcript levels are increased following SC ablation in neonatal
life
We have previously shown that, despite the impact on ALC number following neonatal abla-
tion of SCs, the endocrine function and regulation of the testis (testosterone and luteinizing
hormone (LH) levels) remain largely unaltered in the adult mice [8, 9]. We speculated, there-
fore, whether functional compensation was occurring in the remaining LC population. In
order to test this we quantified the expression of key steroidogenic-related markers by qPCR.
Results show that in adult mice the LC-specific transcripts (corrected for LC number), Lhcgr,
Cyp11a1 (coding for the rate-limiting enzyme in steroid synthesis), Hsd3b6, and Hsd3b1, Star,
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Fig 1. Characterisation of the Leydig cell following Sertoli cell ablation in the neonate. (A) Normal adult testis (postnatal day 80 (pnd80)). Blue arrows indicate
Leydig cells. (B) Adult testis (pnd80) following neonatal Sertoli cell ablation. A large cluster of Leydig cells (blue arrows) is present around the tubuli recti (asterix) and
rete testis (black arrow). Leydig cells from this group in higher power appear similar to normal adult Leydig cells (A, B blue arrows). Immunolocalisation of CYP17A1
(C) and CYP11A1 (D) following Sertoli cell ablation in the neonate showed Leydig cells clustered around the tubuli recti (asterix). There were also small clusters of cells
expressing CYP11A1 and CYP17A1 in the testis parenchyma more distant from the tubuli recti (blue arrows). The morphology of these cells is shown in (E-black
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Cyp17a, Hsd17b3 (coding for the enzyme required for the final step of testosterone biosynthe-
sis), and Sult1e1 were significantly increased (Fig 1G) after neonatal ablation of the SCs. This
increase in LC-specific transcript levels in adult mice, following neonatal SC ablation, suggests
that LC activity is stimulated in these animals. Since transcripts common to both FLC and
ALCs as well as adult-specific transcripts (Hsd3b6, Hsd17b3, Sult1e1) are increased it can be
inferred that the ALCs are showing increased activity. It is not possible to say whether the
FLCs are also affected although previous studies have shown little change in FLC activity in the
short-term following SC ablation [9]. Levels of LH are normal in adult animals following neo-
natal SC ablation suggesting that the LC hyperactivity is due either to altered development of
the cells around puberty or to increased activity in the mature cells because of SC loss. A num-
ber of factors have been postulated to mediate SC-LC communication [17–23] but definitive
studies remain to be carried out.
Following ablation of SCs in adulthood, the remaining ALCs express
functional markers
Next, we assessed the characteristics of the LCs, which persisted following SC ablation in adult-
hood (pnd50). Firstly, we re-confirmed the specific localisation of these LCs on the periphery
of the testis 30 days after SC ablation, as described previously [8]. Based on morphology, char-
acteristic LCs (large round nucleus, abundant cytoplasm) were identified in the sub-capsular
and rete region (Fig 2A-blue arrows) and a mixture of typical LCs as well as vacuolised and
pyknotic LCs were visible in the interstitium (Fig 2A-red and black arrows). The remaining
“morphologically healthy” LCs in the interstitium are functional as shown with markers such
as CYP11A1 and CYP17A1, compared to the pyknotic LCs which do not express these mark-
ers (Fig 2B and 2C), which correlates with the endocrine data [8].
LC-specific transcript levels are altered following SC ablation in adulthood
Following SC ablation in adulthood, circulating testosterone was normal despite only 25% of
the LC population being retained [8]. Consequently, we carried out a transcript analysis to
assess whether the remaining 25% LCs were also functionally compensating for the reduction
in LC population size. Results corrected for LC number show that Cyp11a1 and Insl3 tran-
scripts were significantly increased at all-time points following SC ablation while Hsd17b3,
Fdx1 and Sult1e1 were significantly increased at one or more times. Only Hsd3b6, Cyp17a1
and Lhcgr transcript levels decreased following adult SC ablation (Fig 2D). These results show
that LCs undergo an adaptive response in transcription relating to function in the absence of
SCs in adulthood. This may be different to the compensation mechanism observed when SC
are ablated in neonatal life and may reflect hypersensitivity of the LCs to LH stimulation.
Increased LC steroidogenesis was also seen following SC ablation in adult animals, indicative
of the functional compensation of the remaining 25% of cell [8, 9]. This may be a consequence
of an altered endocrine environment for the cells as SC ablation leads to dysfunction in the tes-
ticular vascular network [24]. It is also possible however, that the SC-independent LCs, which
remain after SC ablation, are functionally different to the other 75% of cells which undergo
apoptosis in the absence of the SCs [8].
arrowhead). For comparison, Leydig cells from a normal neonatal (pnd2) mouse are shown in (F-black arrowhead). These cells have the same morphology as (F). The
black bars represent 50μm, apart from higher power images in A) and B) which are 10μm. (G) Transcript levels measured at pnd80. Results have been normalised to the
number of Leydig cells present in these mice based on data from [9]. Results show mean ± sem of n = 5–8 animals, the significance of difference between individual
groups was determined by post-hoc testing at the P<0.05 levels (�P<0.05). Dtx: Diphtheria treated mice to induce Sertoli cell ablation.
https://doi.org/10.1371/journal.pone.0219524.g001
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Could LC transcripts expression reflect LC cell number?
Our next interrogation focussed on whether we could identify transcripts which would reflect
the number of LCs in the adult testis, as a shorthand way of assessing whether further stereo-
logical analysis was required. Thus, we used models where the reduction of the ALC number
was associated with either a decrease in their progenitor cell recruitment (neonatal ablation)
or a survival defect (prepubertal and adult SC ablation). Moreover, to avoid any misinterpreta-
tion, with regards to the development and function of the ALCs, which are closely related to
LH and androgen stimulation, [11, 25], we set our study in a context where both LH and tes-
tosterone levels are normal but where LC are functionally overactive [8, 9]. To identify candi-
dates, we collated our results on LC number previously obtained following neonatal,
prepubertal and adult SC ablation and published [8, 9] (shown again here to allow direct com-
parison with transcript levels and expressed in percentages-Fig 3A). To determine whether
any of the Leydig cell markers could act as a proxy for Leydig cell numbers, transcript levels
were measured per testis and expressed relative to the external standard (luciferase mRNA)
(Fig 3B). Only Hsd3b6, Star, Cyp17a1, Hsd17b3, Hsd3b1 were significantly reduced following
SC ablation and could, therefore, potentially act a marker of LC number (Fig 3B). Of those
transcripts, however, only Hsd3b1 has been shown to be unresponsive to LH/hCG stimulation
[26], identifying this gene as a potential candidate biomarker for LC population size.
To further confirm the validity of this candidate, we collated data from previous models (S2
Table) such as the SC specific androgen knock-out model (SCARKO) and ethane dimethane
sulphonate (EDS) models where LC number is reduced and testosterone and LH levels are
normal [27, 28]. Within the limits of gene expression examined in each study, we confirmed
that transcript Hsd3b1 is a good indicator of the ALC number in all of these models.
ALC development, maturation and function can be regulated by multiple factors [25] but,
for this study, we selected models where the change in LC number came from either altered
progenitor recruitment or a change in LC survival and where the hormonal background was
not different to control animals [29]. Initially, 5 candidate transcripts were identified, all inde-
pendent of germ cell regulation [30]. Previous data from hpg mice have indicated however, that
most transcripts respond to LH/hCG stimulation with the exception of Hsd3b1 [26, 31, 32].
Limitations
This study identifies Hsd3b1 transcript levels as a potential indicator of LC number with utility
for informing decision-making on whether to engage in time-consuming stereological cell
counting analysis. As HSD3B1 is integral to the principal steroidogenic function of the Leydig
cells it is possible that it may be under endocrine or paracrine control not considered here.
Measurement of transcript levels reported here was based on using an external standard for
the qPCR. This may not be possible in all circumstances and use of housekeeping genes to nor-
malise qPCR results may make interpretation of the data more complex.
Fig 2. Characterisation of the Leydig cell following Sertoli cell ablation in the adulthood. (A) Adult testis (80 days) 30 days after Sertoli
cell ablation at day 50. Large groups of Leydig cells remained present in the subcapsular region of the testis (blue arrows). Some groups of
Leydig cell were present in the interstitium (red arrows) but many showed signs of vacuolisation in the cytoplasm (red arrows) but remained
generally sparse in most interstitial tissue and those that were present often showed reduced cytoplasmic volume or altered nuclear shape (A
black arrows). Immunolocalisation of CYP17A1 (B) and CYP11A1 (C) following Sertoli cell ablation in the adult showed staining within the
interstitium although the number of cells stained was much reduced compared to vehicle animals. The black bars represent 50 μm. (D)
Sertoli cells were ablated in adult animals at 50 days and transcript levels measured up to 365 days later. Results have been normalised to the
number of Leydig cells present in these mice based on data from [8]. Results show mean ± sem of n = 5–8 animals, the significance of
difference between individual groups was determined by post-hoc testing at the P<0.05 levels (�P<0.05). Dtx: Diphtheria treated mice to
induce Sertoli cell ablation.
https://doi.org/10.1371/journal.pone.0219524.g002
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Materials and methods
Animals and treatments
All animal studies passed local ethical review and were conducted with licenced permission
under the UK Animal Scientific Procedures Act (1986), Home Office licence number PPL 60/
4200. Amh-Cre; iDTR mice were generated, genotyped and treated as previously described
[11,12].
RNA extraction, reverse transcription and real-time PCR
Total RNA extraction, reverse transcription, primer design and real-time PCR were carried
out as previously described [11,12][15,16]. RNA was extracted using TRIzol (Life Technolo-
gies, Paisley, UK). Luciferase mRNA (5ng per testis, Promega UK, Southampton, UK) was
added as an external standard to each sample at the start of the RNA extraction procedure.
This controls for the efficiency of RNA extraction, RNA degradation, and the reverse tran-
scription step and allows specific transcript levels to be expressed per testis. Isolated RNA was
reverse transcribed using random hexamers and Moloney murine leukemia virus reverse tran-
scriptase (Superscript III; Life Technologies). For real-time PCR, SYBR mastermix (Brilliant II,
Agilent, Amsterdam, The Netherlands) was mixed with primer (100 nM) and template in a
total volume of 10μl and amplified with an Agilent MX3000 cycler. All primers were designed
by PrimerExpress 2.0 (Applied Biosystems, Warrington, UK). Transcript levels were normal-
ised relative to the luciferase external standard, generating a value of transcript expression per
testis. The primers used are described in S1 Table.
Histology and immunohistochemistry
For histology testes were fixed for 6 hours in Bouin’s solution and then embedded in Technovit
7100 resin. Sections (2.5μm) were cut and stained with H&E. Immunohistochemistry was car-
ried out as described [11,12]; testes were embedded in paraffin and sections (5μm) prepared and
stained using anti-CYP11A1 (rabbit polyclonal, donated by Dr AH Payne, Stanford University)
diluted 1/500 or anti-CYP17A1 (sc-46081 Santa Cruz, lot number F2014, Heidelberg, Germany)
diluted 1/400 and using the appropriate secondary antibodies conjugated to biotin, diluted at 1/
500 in the blocking serum. This step was followed by incubation with horseradish peroxidase
labelled avidin-biotin complex (VectorLabs, Peterborough, UK). The revelation was undertaken
with diaminobenzidine DAB (Immpact DAB;VectorLabs, Peterborough, UK). Slides were coun-
terstained with haematoxylin, dehydrated and mounted with Pertex mounting medium (Cell
Path, Hemel Hempstead, UK). Cell numbers were measured by the optical dissector as previ-
ously shown [8, 9]. The cells were recognised by their position, round nucleus and relatively
abundant cytoplasm. The total testis volume was estimated using the Cavalieri principle.
Statistics
Data sets were analysed using General Linear Modelling. Where this showed a significant over-
all difference, the significance of difference between individual groups was determined by
Fig 3. Identification of Leydig cell markers reflecting the cell number. (A) Leydig cells number following Sertoli cell ablation in neonatal,
prepubertal and adult life, this data, previoulsy published, is shown again here in percentages to allow direct comparison with transcript levels
[8, 9]. (B) Transcript levels measured at the same endpoints as (A) following Sertoli cell ablation in neonatal, prepubertal and adult life.
Results have been normalised to an external control and represent transcript levels per testis. Results show mean ± sem of n = 5–8 animals,
the significance of difference between individual groups was determined by post-hoc testing at the P<0.05 levels (�P<0.05). Dtx: Diphtheria
treated mice to induce Sertoli cell ablation.
https://doi.org/10.1371/journal.pone.0219524.g003
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post-hoc testing at the P<0.05 levels. Data was log transformed where appropriate to avoid
heterogeneity of variance. Data was analysed using Minitab 15 (Minitab Ltd, Coventry, UK) or
Graph Prism version 8 (GraphPad Software Inc., San Diego, CA, USA).
Supporting information
S1 Table. Primer list.
(XLSX)
S2 Table. List of models exhibiting Leydig cell number decrease.
(PDF)
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